Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
24.88
-1.21 (-4.64%)
Mar 3, 2026, 4:00 PM EST - Market closed
Elanco Animal Health Revenue
In the year 2025, Elanco Animal Health had annual revenue of $4.72B with 6.22% growth. Elanco Animal Health had revenue of $1.14B in the quarter ending December 31, 2025, with 12.16% growth.
Revenue (ttm)
$4.72B
Revenue Growth
+6.22%
P/S Ratio
2.62
Revenue / Employee
$476,263
Employees
9,900
Market Cap
12.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.72B | 276.00M | 6.22% |
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
| Dec 31, 2015 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 17.26B |
| Haleon | 14.85B |
| Viatris | 14.30B |
| Dr. Reddy's Laboratories | 3.85B |
| United Therapeutics | 3.18B |
| Amneal Pharmaceuticals | 3.02B |
| Neurocrine Biosciences | 2.86B |
| Hims & Hers Health | 2.35B |
ELAN News
- 19 hours ago - Baron Health Care Fund Q4 2025 Recent Activity - Seeking Alpha
- 1 day ago - Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 5 days ago - Elanco Animal Health Incorporated (ELAN) Presents at BofA Securities Animal Health Summit Transcript - Seeking Alpha
- 7 days ago - Elanco Animal Health Incorporated (ELAN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results - PRNewsWire
- 12 days ago - Elanco to Participate in Upcoming Investor Conferences - PRNewsWire
- 18 days ago - Elanco Announces Updates to Board of Directors - PRNewsWire
- 5 weeks ago - Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement - PRNewsWire